In the years following the DePuy ASR hip implant recall, several patients have filed lawsuits against the manufacturing company and have benefited from a DePuy ASR hip settlement.

At least half a million Americans have received hip replacement surgeries, and many of them have received a DePuy ASR hip implant. This product became the subject of a massive recall in August 2010.

Some of the problems that have been reported with a DePuy ASR hip replacement surgery include suffering from a dislocated hip, cancer, the leaking of toxic substances into the bloodstream, degenerative heart disease, loss of bone strength, metallosis, and non-cancerous tumors.

Overview: DePuy ASR Hip

Thousands of patients who have received a DePuy ASR hip implant have accused the company of failing to adequately warn patients of the adverse effects that a metal-on-metal hip replacement implant can cause.

Johnson & Johnson, DePuy’s parent company, agreed to a multi-billion-dollar settlement agreements and has even lost multi-million-dollar jury verdicts because of allegations of DePuy ASR hip implant complications.

The DePuy ASR XL Acetabular Cup component is part of a system designed to replace a patient’s hip joint as part of a total hip replacement. The acetabular cup is comprised of a cobalt-chrome-molybdenum (CoCrMo) metal.

Although the device was once advertised to be safer and more durable than other previous hip implant models, patients allege the device was not as safe as it was marketed to be. Many patients implanted with the ASR XL Acetabular hip model say they experienced severe complications that would often lead to revision surgeries.

The reported complications included an increased risk of cancer, pain, swelling, severe discomfort, inflammation, and premature failure of the hip implant.

Voluntary DePuy ASR Hip Recall

On Aug. 24, 2010, the U.S. Food and Drug Administration (FDA) announced a voluntary DePuy ASR hip recall. The recall covered 93,000 ASR hip implants distributed around the world. There were 37,000 DePuy ASR hip products recalled from within the United States.

The recall resulted after data was released from the UK joint registry that found that 13 percent of DePuy ASR hip implant patients required revision surgery. This was due to severe adverse effects and severe complications which led to earlier revision surgeries than previously expected.

DePuy ASR Hip Lawsuit

Nearly 10,000 patients have filed lawsuits against the companies for DePuy ASR hip damages.

Claims filed against the company include fraud, gross negligence and malice, failure to warn, and willfully concealing the risks involved with a DePuy ASR hip device from patients and the general public.

Plaintiffs filing DePuy ASR hip implant lawsuits allege that the device was defectively designed. Studies have concluded that the metal-on-metal hip implant device has been linked to a high failure rate caused by conditions such as dislocation, immobility, infection, and metallosis.

To settle the large portion of legal claims, the company also agreed to a $4 billion dollar settlement. The DePuy ASR hip settlement now covers patients who have undergone a hip revision surgery since March 2015.